455
Views
111
CrossRef citations to date
0
Altmetric
Original

Risk Factors for Cardiovascular Disease in Women with a History of Pregnancy Complicated by Preeclampsia or Intrauterine Growth Restriction

, Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D. & , Ph.D.
Pages 39-50 | Published online: 07 Jul 2009

REFERENCES

  • Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451
  • Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–898
  • Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501–509
  • Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–1204
  • Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648–655
  • Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002; 325: 157–160
  • Irgens HU, Reisæter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213–1217
  • Smith GSC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129290 births. Lancet 2001; 357: 2002–2006
  • He S, Silveira A, Hamsten A, Blombäck M, Bremme K. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost 1999; 81: 538–542
  • Davey Smith G, Harding S, Rosato M. Relation between infants' birth weight and mothers' mortality: prospective observational study. BMJ 2000; 320: 839–840
  • Dahlén GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994; 108: 111–126
  • Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease; meta-analysis of prospective studies. Circulation 2000; 102: 1082–1085
  • Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 1989; 339: 301–303
  • Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303–306
  • Manten GTR, Voorbij HAM, Hameeteman TM, Visser GHA, Franx A. Lipoprotein (a) in pregnancy: A critical review of the literature. Eur J Obstet Gynecol Reprod Biol 2005; 122: 13–21
  • Wang J, Mimuro S, Lahoud R, Trudinger B, Wang XL. Elevated levels of lipoprotein (a) in women with preeclampsia. Am J Obstet Gynecol 1998; 178: 146–146
  • Kloosterman GJ. On intrauterine growth. Int J Obstet Gynecol 1970; 8: 895–912
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1)S5–S10
  • Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop preeclampsia?. J Hypertens 1999; 17: 1307–1315
  • Hubel CA, Snaedal S, Ness RB, Weissfeld LA, Geirsson RT, Roberts JM, Arngrímsson R. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. Br J Obstet Gynaecol 2000; 107: 776–784
  • Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177: 1003–1010
  • Solomon CG, Seely EW. Hypertension in pregnancy; a manifestation of the insulin resistance syndrome?. Hypertension 2001; 37: 232–239
  • Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 15: 465–471
  • Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999; 48: 892–896
  • Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57–63
  • Rodie VA, Freeman DJ, Sattar N, Greer IA. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis 2004; 175: 189–202
  • Barker DJP. Mother's, Babies and Disease in Later Life. BMJ Publishing Group, London 1994
  • Hubel CA, Snaedal S, Ness RB, Weissfeld LA, Geirsson RT, Roberts JM, et al. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. BJOG 2000; 107: 776–784
  • Leerink CB, de Vries CVS, van der Klis FRM. Elevated levels of serum lipoprotein (a) and apolipoprotein (a) phenotype are not related to pre-eclampsia. Acta Obstet Gynecol Scand 1997; 76: 625–628
  • van Pampus MG, Koopman MMW, Wolf H, Büller HR, Prins MH, van den Ende A. Lipoprotein (a) concentrations in women with a history of severe preeclampsia; a case control study. Thromb Haemost 1999; 82: 10–13
  • Bar J, Harell D, Bardin R, Pardo J, Chen R, Hod M, et al. The elevated plasma lipoprotein (a) concentrations in preeclampsia do not precede the development of the disorder. Thromb Res 2002; 105: 19–23
  • Lippi G, Braga V, Adami S, Guidi G. Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein (a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 1998; 271: 79–87
  • Ogunyemi D, Ku W, Arkel Y. The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy. J Thromb Thrombolysis 2002; 14: 157–162
  • Berg K, Roald B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1994; 46: 52–56
  • Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51–61

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.